Neurorehabilitation Devices - Market Scope
Neurological rehabilitation is a doctor-supervised program designed for people with diseases, injuries, or disorders of the nervous system. Neurological rehab can often improve function, reduce symptoms, and improve the well-being of the patient. Neurorehabilitation Device uses this technique in the field of physiotherapy. Regardless of the cause of the disability, most neurological rehabilitation devices are intended to facilitate the learning or relearning of motor skills. Development in neuroimaging techniques has greatly enhanced the scope and outcome of neurorehabilitation. Neurorehabilitation devices include non-invasive brain stimulators, neurorobotics systems, brain-computer interfaces, and wearable devices. Increased prevalence and incidence of neurological disorders are key drivers of growth and demand for Neurorehabilitation equipment.
|Unit||Value (USD Million)|
|Key Companies Profiled||NeuroPace, Inc. (United States), Mindmaze (Switzerland), Neuros Medical (United States), Flow Neuroscience (Sweden), NEURALINK (United States), Hocona AG (Switzerland), BrainCo, Inc. (United States), Medtronic (Ireland), Synchron (United States), Halo Neuroscience (United States) and usMIMA. (United States)|
Competition among existing players is due to the stiff market share occupied by leading players. The industry leader is engaged in offering innovative and superior-quality products to cater to the ever-growing demand for neurorehabilitation devices. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Neurorehabilitation Devices - market throughout the predicted period.
NeuroPace, Inc. (United States), Mindmaze (Switzerland), Neuros Medical (United States), Flow Neuroscience (Sweden), NEURALINK (United States), Hocona AG (Switzerland), BrainCo, Inc. (United States), Medtronic (Ireland), Synchron (United States), Halo Neuroscience (United States) and usMIMA. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Rehabtronics Inc (Canada), Thync Global, Inc. (United States), Kernel (United States), Rehab Robotics (Hong Kong), Tyromotion GmbH (AUSTRIA) and NextStep Robotics (United States).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global Neurorehabilitation Devices - market by Type , by Application (Parkinson's disease, Bran trauma injury, Spinal cord injury, Stroke, Schizophrenia, Cerebral palsy and Others) and Region with country level break-up.
On the basis of geography, the market of Neurorehabilitation Devices - has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.
Market Leaders and their expansionary development strategiesIn November 2018, Neurocognitive rehabilitation company MindMaze acquires Neuro Motor Innovations Corporation, It’s an artificial intelligence-powered video game that stroke patients control through controlled motor functions. The offering is designed to treat neurological diseases and injuries both acute and chronic.
In August 2021, NeuroPace launches epilepsy platform to personalize seizure care, California-based NeuroPace launched a new portal, called the nSight Platform. It's able to gather information about a patient's seizures and health progress outside of a hospital.
Influencing Trend:Rising cases of neurological disorders and the availability of numerous approved devices
Market Growth Drivers:Neurorehabilitation devices also have a real potential to save patients money
Challenges:The government pays less attention to rehab services
Restraints:Lack of skilled specialists in the Neurorehabilitation devices markets
Opportunities:Growing demand of Functional electrical stimulation and Virtual reality rehabilitation having in wearable technology
Key Target AudienceManufacturers, suppliers, Governments regulatory, Industry Experts, End Users and Others